Antihistamines in the management of allergic pruritus in dogs and cats

Journal of Small Animal Practice

Volumn 40, Issue 8, 1999, Pages 359-364

  Scott, D W ^a   Miller Jr , W H ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H1 RECEPTOR ANTAGONIST;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; DOG; DOG DISEASE; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; PRURITUS; STANDARD; VETERINARY MEDICINE;

ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; HISTAMINE H1 ANTAGONISTS; HYPERSENSITIVITY, IMMEDIATE; PRURITUS; VETERINARY MEDICINE;

EID: 0033175994     PISSN: 00224510     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-5827.1999.tb03099.x     Document Type: Article

References (50)

1. AWOUTERS, F. (1980) Oxatomide: the prototype of a chemical series of compounds inhibiting both the release and effects of allergic mediators. In: Drugs Affecting the Respiratory System. Ed D. L. Temple. American Chemical Society, Washington. pp 179-208
2. AWOUTERS, F., VERMEIRE, J., SMEYERS, F., VERMOTE, P., VAN BEEK, R. & NIEMEGEERS, C. J. (1986) Oral antiallergic activity in Ascaris hypersensitive dogs: a study of known antihistamines and of the new compounds ramastine (R57 959) and levocabastine (R50 547). Drug Development Research 8, 95-102
3. BOURDEAU, P. & PARAGON, B. M. (1992) Alternatives aux corticoïdes en dermatologie des carnivores. Recueil de Médecine Vétérinaire 168, 645-660
4. CHARLESWORTH, E. N., KAGEY-SABOTKA, A. & NORMAN, P. S. (1989) Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. Journal of Allergy and Clinical Immunology 83, 905-912
5. 1-antihistamines on histamine release from dispersed canine cutaneous mast cells. American Journal of Veterinary Research 58, 293-297
6. GIBSON, J. P., HUFFMAN, K. W. & NEWBERNE, J. W. (1982) Practical safety studies with terfenadine. Arzneimittelforschung 32, 1179-1184
7. HARVEY, R. G. (1995) Systemic nonsteroidal therapy for pruritus: the European experience. Proceedings of the Annual Waltham/Ohio State University Symposium for the Treatment of Small Animal Disease, Columbus, OH, October 19, 27-31
8. HÉRIPRET, D. (1993) Les antiprurigineux non stéroïdiens. Pratique Médicale et Chirurgicale de l' Animal de Compagnie 28, 73-80
9. HÉRIPRET, D. (1996a) Étude d'un antihistaminique, l'oxatomide (Tinset ND): données bibliographiques et expérimentales. Pratique Médicale et Chirurgicale de l'Animal de Compagnie 31, 41-49
10. HÉRIPRET, D. (1996b) Intérêt clinique de l' oxatomide (Tinset ND) en allergologie canine: résultats d'une étude ouverte sur 136 chiens. Pratique Médicale et Chirurgicale de l' Animal de Compagnie 31, 51-56
11. HÉRIPRET, D. & VROOM, M. (1998) Antipruritic therapy. In: Advances in Veterinary Dermatology III. Eds K. W. Kwochka, T. Willemse and C. Von Tscharner. Butterworth-Heinnemann, Boston. pp 417-418
12. HIRSHMAN, C. A., AUSTIN, D. R. & KETTLEKAMP, N. S. (1988) Enhanced bronchoalveolar lavage mast cells histamine releasability in allergic dogs with and without airway hyperresponsiveness. Journal of Allergy and Clinical Immunology 81, 829-835
13. 3H by the rat and dog. Biochemical Pharmacology 18, 659-671
14. LEESON, G. A., CHAN, K. Y. & KNAPP, W. C. (1982) Metabolic disposition of terfenadine in laboratory animals. Arzneimittelforschung 32, 1173-1178
15. LOGAS, D. (1995) Systemic nonsteroidal therapy for pruritus: the North American experience. Proceedings of the Annual Waltham/Ohio State University Symposium for Treatment of Small Animal Disease, Columbus, OH, October 19, 32-36
16. MCEVOY, G. K. (1998) AHFS 98 Drug Information. American Society of Health-System Pharmacists, Bethesda. pp 2-47
17. 1-antagonists on EEG activity and behaviour in the cat. Pharmacology, Biochemistry and Behaviour 32, 861-866
18. 1 antagonism in allergic inflammation. Journal of Allergy and Clinical Immunology 86, 1019-1024
19. MESSINGER, L. M. (1995) Therapy for feline dermatoses. Veterinary Clinics of North America: Small Animal Practice 25, 981-1005
20. MILLER, W. H. JR (1989) Nonsteroidal antiinflammatory agents in the management of canine and feline pruritus. In: Current Veterinary Therapy X. Ed R. W. Kirk. W. B. Saunders, Philadelphia. pp 566-569
21. MILLER, W. H. JR & SCOTT D. W. (1990) Efficacy of chlorpheniramine maleate for the management of pruritus in cats. Journal of the American Veterinary Medical Association 197, 67-170
22. MILLER, W. H. JR & SCOTT, D. W. (1994) Clemastine fumarate as an antipruritic agent in pruritic cats: results of an open clinical trial. Canadian Veterinary Journal 35, 502-504
23. MILLER, W. H. JR, SCOTT, D. W. & WELLINGTON, J. R. (1992) Nonsteroidal management of canine pruritus with amitriptyline. Cornell Veterinarian 82, 53-57
24. MILLER, W. H. JR, SCOTT, D. W. & WELLINGTON, J. R. (1993) A clinical trial on the efficacy of clemastine in the management of allergic pruritus in dogs. Canadian Veterinary Journal 34, 25-27
25. MULLER, G. H. & KIRK, R. W. (1969) Small Animal Dermatology. W. B. Saunders, Philadelphia. p 236
26. NORRIS, C. R., BOOTHE, D. M., ESPARTA, T., GRAY, C. & RAGSDALE, M. (1998) Disposition of cyproheptadine in cats after intravenous or oral administration of a single dose. American Journal of Veterinary Research 59, 79-81
27. OTTO, C. M. & GREENTREE, W. F. (1994) Terfenadine toxicosis in dogs. Journal of the American Veterinary Medical Association 205, 1004-1006
28. PARADIS, M. (1996) Nonsteroidal antipruritic drugs in dogs and cats: an update. Bulletin of the Canadian Academy of Veterinary Dermatology 12, 3-7
29. PARADIS, M., LEMAY, S. & SCOTT, D. W. (1991a) The efficacy of clemastine (Tavist), a fatty acid-containing product (Derm Caps), and the combination of both products in the management of canine pruritus. Veterinary Dermatology 2, 17-20
30. PARADIS, M., SCOTT, D. W. & GIROUX, D. (1991b) Further investigations on the use of nonsteroidal and steroidal antiinflammatory agents in the management of canine pruritus. Journal of the American Animal Hospital Association 27, 44-48
31. PATERSON, S. (1994) Use of antihistamines to control pruritus in atopic dogs. Journal of Small Animal Practice 35, 415-419
32. PATERSON, S. (1995) Additive benefits of EFAs in dogs with atopic dermatitis after partial response to antihistamine therapy. Journal of Small Animal Practice 36, 389-394
33. PROST, C. (1993) Les dermatoses allergiques du chat. Pratique Médicale et Chirurgicale de l' Animal de Compagnie 28, 151-164
34. SAUNDERS, L. (1978) Antihistamines are effective in the atopic dog. Veterinary Allergist Summer, 2-4
35. SCOTT, D. W. & BUERGER, R. G. (1988) Nonsteroidal antiinflammatory agents in the management of canine pruritus. Journal of the American Animal Hospital Association 24, 425-428
36. SCOTT, D. W. & MILLER, W. H. JR (1990) Nonsteroidal management of canine pruritus: chlorpheniramine and a fatty acid supplement (DVM Derm Caps) in combination, and the fatty acid supplement at twice the manufacturer's recommended dosage. Cornell Veterinarian 80, 381-387
37. SCOTT, D. W. & MILLER, W. H. JR (1993a) Nonsteroidal anti-inflammatory agents in the management of canine allergic pruritus. Journal of the South African Veterinary Association 64, 52-56
38. SCOTT, D. W. & MILLER, W. H. JR (1993b) Medical management of allergic pruritus in the cat, with emphasis on feline atopy. Journal of the South African Veterinary Association 64, 103-108
39. SCOTT, D. W. & MILLER, W. H. JR (1995) The combination of an antihistamine (chlorpheniramine) and an omega-3/omega-6 fatty acid-containing product for the management of pruritic cats: results of an open clinical trial. New Zealand Veterinary Journal 43, 29-31
40. SCOTT, D. W., MILLER, W. H. JR, CAYATTE, S. M. & DECKER, G. A. (1994) Failure of terfenadine as an antipruritic agent in atopic dogs: results of a double-blinded, placebo-controlled study. Canadian Veterinary Journal 35, 286-288
41. SCOTT, D. W., MILLER, W. H. JR, DECKER, G. A., & CAYATTE, S. M. (1992) Failure of cyproheptadine hydrochloride as an antipruritic agent in allergic dogs: results of a double-blinded, placebo-controlled study. Cornell Veterinarian 82, 247-251
42. SCOTT, D. W., ROTHSTEIN, E., BENINGO, K. E. & MILLER, W. H. JR (1998) Observations on the use of cyproheptadine hydrochloride as an antipruritic agent in allergic cats. Canadian Veterinary Journal 39, 634-637
43. TAYLOR, D. C. (1978) The metabolism and elimination of cimetidine, a histamine H2-receptor antagonist, in the rat, dog, and man. Drug Metabolism and Disposition 6, 21-30
44. TING, S., PAULS, D. O. & REIMAN B. E. F. (1985) Inhibiting effect of hydroxyzine on antigen-induced histamine release in vivo. Journal of Clinical Immunology 75, 63-66
45. TOGIAS, A. G., NACLERIO, R. M., WARNER, J., FREIDHOFF, L., LICHTENSTEIN, L. M. & NACLERIO, R. M. (1986) Demonstration of inhibition of mediator release from human mast cells by azatadine base. Journal of the American Medical Association 255, 225-229
46. TOGIAS, A. G., PROUD, D. & KAGEY-SOBOTKA, A. (1989) In vivo and in vitro effects of antihistamines on mast cell mediator release, a potentially important property in the treatment of allergic disease. Annals of Allergy 63, 465-469
47. VAN STEE, E. W. (1981) Alternative to corticosteroids in the management of pruritus in dogs. Veterinary Medicine/Small Animal Clinician 76, 331-333
48. WAUQUIER, A., VAN DEN BROECK, W. A. E., AWOUTERS, F. & JANSSEN, P. A. J. (1984) Further studies on the distinctive sleep wakefulness profiles of antihistamines (astemizole, ketotifen, terfenadine) in dogs. Drug Development Research 4, 617-625
49. YASKULSKI, S. G. (1978) Antipruritic therapy. California Veterinarian 32, 14-16
50. YOXALL, A. T. (1979) A clinical trial of oxatomide in canine atopic dermatitis. Proceedings of the European Congress of Veterinary Pharmacology and Toxicology 1, 348-349